Combination of solifenacin and mirabegron for overactive bladder management.
Department of Urology, Tenon Hospital, Hôpitaux Universitaires Paris-EST, Assistance publique Hôpitaux de Paris, Université Pierre et Marie Curie Paris 6, Paris, France.
Jean-Nicolas
JN
Cornu
D000083:Acetanilides / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D000069464:Solifenacin Succinate / Q000627:therapeutic use*; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D064804:Urological Agents / Q000009:adverse effects* / Q000627:therapeutic use*
D000083:Acetanilides; D013844:Thiazoles; D064804:Urological Agents; D000069464:Solifenacin Succinate